IBOV 175,664.62 ▲ 0.30% IPSA 11,445.90 ▼ 0.22% IPC MEX 65,561.46 ▼ 0.41% MERVAL 2,979,472 ▼ 0.72% COLCAP 2,457.87 ▼ 1.28% BVL PERÚ 60,779.49 ▼ 1.40% USD/BRL5.19▲ 0.45% USD/MXN17.03▲ 0.26% USD/CLP930.58▲ 0.45% USD/COP3,202▲ 2.39% USD/PEN3.35▼ 0.07% USD/ARS1,512— 0.00% USD/UYU40.27▲ 1.50% USD/PYG5,900▲ 0.50% USD/BOB11.78▲ 3.59% USD/DOP58.61▲ 0.96% USD/CRC446.65▲ 0.98% USD/GTQ7.62▲ 2.25% USD/HNL26.84▲ 0.40% USD/NIO36.62▼ 0.02% USD/VES789.69▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.72▲ 0.77% EUR/BRL6.01▲ 0.17% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 175,664.62 ▲ 0.30% IPSA 11,445.90 ▼ 0.22% IPC MEX 65,561.46 ▼ 0.41% MERVAL 2,979,472 ▼ 0.72% COLCAP 2,457.87 ▼ 1.28% BVL PERÚ 60,779.49 ▼ 1.40% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Saturday, August 29, 2026

British MP: “The scale of the damage caused by Covid vaccines is a nightmare”

By · March 16, 2022 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – A member of the British Parliament (M.P.) described the scale of damage caused by the Wuhan coronavirus (Covid-19) vaccine as a ‘nightmare’ as he called on Downing Street to provide more support to those affected.

Conservative MP Christopher Chope, who represents Christchurch in the House of Commons, noted that tens of thousands of Britons had suffered vaccine damage after being vaccinated.

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

Earlier, he told a session of the U.K. Parliament that the extent of injuries caused by the Covid-19 vaccine “now exceeds any cases resulting from previous vaccination programs.”

“The public will finally understand what damage has been done. There are many people out there who did the right thing … [who] are not getting the help from the government that they thought they should be getting. That’s where I stand.”

According to Chope, he submitted a file to Downing Street with cases of injuries related to the Covid-19 vaccine – but was met only with “relative silence.” He continued, “[What] I read last summer suggested that people were having adverse reactions to vaccines and that it was difficult for them to get compensation.”

Chope then introduced another bill in Parliament to expand the compensation system, and the 20-minute debate on the measure resulted in “many” email responses from across the U.K.

The Christchurch MP shared the story of Julian Gooddy, who suffered vaccine damage two weeks after receiving an injection of AstraZeneca’s Covid-19 vaccine. Gooddy suffered several problems after the vaccination, including Bell’s palsy, fatigue, and limb pain.

He was later diagnosed with Guillain-Barré syndrome (GBS), a disease in which the immune system attacks the protective layer of nerve cells.

“It was frustrating because of the lack of acceptance that there was a causal link between the [AstraZeneca] vaccine I had and GBS,” he lamented.

Chope calls on Downing Street to improve vaccine injury compensation.

In light of Gooddy’s story, Chope said he is calling on the U.K. government to be proactive and raise awareness of the Vaccine Injury Payment System (VDPS) – particularly for those who have downloaded the U.K. Yellow Card reports system.

The Yellow Card system is the U.K. equivalent of the Vaccine Adverse Event Reporting System.

The VPDS was launched in 1979 and later expanded to include vaccinations against Covid-19. Under this program, Britons who can prove severe disability or death as a result of immunization can receive tax-free compensation of £120,000 (US$156,000).

None of the 920 vaccine injury compensation claimants has received the amount as of this writing.

The MP for Lewes, Maria Caulfield, parliamentary under-secretary for patient safety and primary care, answered Chope’s questions.

The Conservative MP told her colleague that the Medicines and Healthcare products Regulatory Agency is looking through the notes of all affected patients to investigate any link between the vaccine and the severe reactions.

The U.K. Medicines and Healthcare Products Regulatory Agency was also reviewing the GBS reports, adding that all information would be shared as soon as it was available.

“We estimate that the process will take an average of six months. This requires having access to the individuals’ medical records and their medical history.

Although someone may have reacted that day, we can’t say with certainty that there is a causal link between the vaccine and the adverse event until we review all the evidence – although there may be a strong indication that there is. So it’s essential to follow this process correctly,” Caulfield said.

 

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.